Skip to main content

Featured

Market Jitters Return as Cooler CPI Surprises Wall Street

A softer‑than‑expected U.S. Consumer Price Index reading sent a ripple through financial markets today, creating an unusual dynamic: good news on inflation, but renewed pressure on major stock indexes. A Cooling CPI, but a Nervous Market The latest CPI report showed inflation easing more than economists anticipated. Under normal circumstances, that would be a welcome sign—suggesting the Federal Reserve may have more room to consider rate cuts later in the year. But markets don’t always behave logically in the moment. Today, the S&P 500, Dow Jones Industrial Average, and Nasdaq all slipped as investors reassessed what the data means for corporate earnings, interest‑rate expectations, and the broader economic outlook. Why Stocks Reacted This Way Several factors contributed to the pullback: Profit‑taking after recent market highs Concerns that cooling inflation reflects slowing demand Uncertainty about the Fed’s next move , even with softer price pressures Sector rotation ...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment